A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design

被引:623
作者
Beno, Brett R. [1 ]
Yeung, Kap-Sun [2 ]
Bartberger, Michael D. [3 ]
Pennington, Lewis D. [3 ]
Meanwell, Nicholas A. [2 ]
机构
[1] Bristol Myers Squibb Res & Dev, Dept Comp Assisted Drug Design, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Res & Dev, Dept Discovery Chem, Wallingford, CT 06492 USA
[3] Amgen Inc, Dept Therapeut Discovery, Thousand Oaks, CA 91320 USA
关键词
CENTER-DOT-O; INOSINE MONOPHOSPHATE DEHYDROGENASE; TYROSINE KINASE INHIBITORS; SIDE-CHAIN INTERACTIONS; OXIDATION-REDUCTION POTENTIALS; CAMBRIDGE STRUCTURAL DATABASE; CONTAINING NATURAL-PRODUCTS; FACTOR XA INHIBITORS; DOUBLE-MUTANT CYCLES; CIS-TRANS ISOMERISM;
D O I
10.1021/jm501853m
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Electron deficient, bivalent sulfur atoms have two areas of positive electrostatic potential, a Consequence of the low-lying sigma* orbitals of the C-S bond that are available for interaction with electron donors including oxygen and nitrogen atoms and, possibly, pi-systems. Intramolecular interactions are by far the most common manifestation of this effect, which offers a means of modulating the conformational preferences of a molecule. Although a well-documented phenomenon, a priori applications in drug design are relatively sparse and this interaction, which is often isosteric with an intramolecular hydrogen-bonding interaction, appears to be underappreciated by the medicinal chemistry community. In this Perspective, we discuss the theoretical basis for sulfur sigma* orbital interactions and illustrate their importance in the context of drug design and organic synthesis. The role of sulfur interactions in protein structure and function is discussed and although relatively rare, intermolecular interactions between ligand C-S sigma* orbitals and proteins are illustrated.
引用
收藏
页码:4383 / 4438
页数:56
相关论文
共 341 条
[1]   Crystal structures of two potent nonamidine inhibitors bound to factor Xa [J].
Adler, M ;
Kochanny, MJ ;
Ye, B ;
Rumennik, G ;
Light, DR ;
Biancalana, S ;
Whitlow, M .
BIOCHEMISTRY, 2002, 41 (52) :15514-15523
[2]   CHEMISTRY OF HYPERVALENT SULFUR .4. STRUCTURE OF 1-1 ADDUCT OF HECTORS BASE WITH ARYLCYANAMIDES BOND SWITCH ON HYPERVALENT SULFUR [J].
AKIBA, K ;
TSUCHIYA, T ;
INAMOTO, N ;
ONUMA, K ;
NAGASHIMA, N ;
NAKAMURA, A .
CHEMISTRY LETTERS, 1976, (07) :723-726
[3]  
AKIBA KY, 1976, TETRAHEDRON LETT, P3819
[4]   Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors [J].
Alam, Mahbub ;
Beevers, Rebekah E. ;
Ceska, Tom ;
Davenport, Richard J. ;
Dickson, Karen M. ;
Fortunato, Mara ;
Gowers, Lewis ;
Haughan, Alan F. ;
James, Lynwen A. ;
Jones, Mark W. ;
Kinsella, Natasha ;
Lowe, Christopher ;
Meissner, Johannes W. G. ;
Nicolas, Anne-Lise ;
Perry, Benjamin G. ;
Phillips, David J. ;
Pitt, William R. ;
Platt, Adam ;
Ratcliffe, Andrew J. ;
Sharpe, Andrew ;
Tait, Laura J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) :3463-3467
[5]   Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinase [J].
Albrecht, Brian K. ;
Harmange, Jean-Christophe ;
Bauer, David ;
Berry, Loren ;
Bode, Christiane ;
Boezio, Alessandro A. ;
Chen, April ;
Choquette, Deborah ;
Dussault, Isabelle ;
Fridrich, Cary ;
Hirai, Satoko ;
Hoffman, Doug ;
Larrow, Jay F. ;
Kaplan-Lefko, Paula ;
Lin, Jasmine ;
Lohman, Julia ;
Long, Alexander M. ;
Moriguchi, Jodi ;
O'Connor, Anne ;
Potashman, Michele H. ;
Reese, Monica ;
Rex, Karen ;
Siegmund, Aaron ;
Shah, Kavita ;
Shimanovich, Roman ;
Springer, Stephanie K. ;
Teffera, Yohannes ;
Yang, Yajing ;
Zhang, Yihong ;
Bellon, Steven F. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (10) :2879-2882
[6]   The Cambridge Structural Database: a quarter of a million crystal structures and rising [J].
Allen, FH .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 2002, 58 (3 PART 1) :380-388
[7]   BONDING BETWEEN NONBONDED SULFUR AND OXYGEN-ATOMS IN SELECTED ORGANIC-MOLECULES (A QUANTUM CHEMICAL STUDY) [J].
ANGYAN, JG ;
POIRIER, RA ;
KUCSMAN, A ;
CSIZMADIA, IG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (08) :2237-2245
[8]   NATURAL BETA-LACTAM ANTIBIOTICS [J].
AOKI, H ;
OKUHARA, M .
ANNUAL REVIEW OF MICROBIOLOGY, 1980, 34 :159-181
[9]   Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature [J].
Arnison, Paul G. ;
Bibb, Mervyn J. ;
Bierbaum, Gabriele ;
Bowers, Albert A. ;
Bugni, Tim S. ;
Bulaj, Grzegorz ;
Camarero, Julio A. ;
Campopiano, Dominic J. ;
Challis, Gregory L. ;
Clardy, Jon ;
Cotter, Paul D. ;
Craik, David J. ;
Dawson, Michael ;
Dittmann, Elke ;
Donadio, Stefano ;
Dorrestein, Pieter C. ;
Entian, Karl-Dieter ;
Fischbach, Michael A. ;
Garavelli, John S. ;
Goeransson, Ulf ;
Gruber, Christian W. ;
Haft, Daniel H. ;
Hemscheidt, Thomas K. ;
Hertweck, Christian ;
Hill, Colin ;
Horswill, Alexander R. ;
Jaspars, Marcel ;
Kelly, Wendy L. ;
Klinman, Judith P. ;
Kuipers, Oscar P. ;
Link, A. James ;
Liu, Wen ;
Marahiel, Mohamed A. ;
Mitchell, Douglas A. ;
Moll, Gert N. ;
Moore, Bradley S. ;
Mueller, Rolf ;
Nair, Satish K. ;
Nes, Ingolf F. ;
Norris, Gillian E. ;
Olivera, Baldomero M. ;
Onaka, Hiroyasu ;
Patchett, Mark L. ;
Piel, Joern ;
Reaney, Martin J. T. ;
Rebuffat, Sylvie ;
Ross, R. Paul ;
Sahl, Hans-Georg ;
Schmidt, Eric W. ;
Selsted, Michael E. .
NATURAL PRODUCT REPORTS, 2013, 30 (01) :108-160
[10]   SAR-based optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as highly potent EP1 receptor antagonists [J].
Atobe, Masakazu ;
Naganuma, Kenji ;
Kawanishi, Masashi ;
Morimoto, Akifumi ;
Kasahara, Ken-ichi ;
Ohashi, Shigeki ;
Suzuki, Hiroko ;
Hayashi, Takahiko ;
Miyoshi, Shiro .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (24) :6569-6576